AUT LibraryAUT
View Item 
  •   Open Research
  • AUT Faculties
  • Faculty of Design and Creative Technologies (Te Ara Auaha)
  • School of Engineering, Computer and Mathematical Sciences - Te Kura Mātai Pūhanga, Rorohiko, Pāngarau
  • View Item
  •   Open Research
  • AUT Faculties
  • Faculty of Design and Creative Technologies (Te Ara Auaha)
  • School of Engineering, Computer and Mathematical Sciences - Te Kura Mātai Pūhanga, Rorohiko, Pāngarau
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Bioengineering silicon quantum dot theranostics using a network analysis of metabolomic and proteomic data in cardiac ischemia

Erogbogbo, F; May, J; Swihart, M; Prasad, P; Smart, K; Jack, S; Korcyk, D; Webster, M; Stewart, R; Zeng, I; Jullig, M; Bakeev, K; Jamieson, M; Kasabov, N; Gopalan, B; Liang, L; Hu, R; Schliebs, S; Villas-Boas, S; Gladding, P
Thumbnail
View/Open
SiQD Theranostics.pdf (2.110Mb)
Permanent link
http://hdl.handle.net/10292/6999
Metadata
Show full metadata
Abstract
Metabolomic profiling is ideally suited for the analysis of cardiac metabolism in healthy and diseased states. Here, we show that systematic discovery of biomarkers of ischemic preconditioning using metabolomics can be translated to potential nanotheranostics. Thirty-three patients underwent percutaneous coronary intervention (PCI) after myocardial infarction. Blood was sampled from catheters in the coronary sinus, aorta and femoral vein before coronary occlusion and 20 minutes after one minute of coronary occlusion. Plasma was analysed using GC-MS metabolomics and iTRAQ LC-MS/MS proteomics. Proteins and metabolites were mapped into the Metacore network database (GeneGo, MI, USA) to establish functional relevance. Expression of 13 proteins was significantly different (p<0.05) as a result of PCI. Included amongst these was CD44, a cell surface marker of reperfusion injury. Thirty-eight metabolites were identified using a targeted approach. Using PCA, 42% of their variance was accounted for by 21 metabolites. Multiple metabolic pathways and potential biomarkers of cardiac ischemia, reperfusion and preconditioning were identified. CD44, a marker of reperfusion injury, and myristic acid, a potential preconditioning agent, were incorporated into a nanotheranostic that may be useful for cardiovascular applications. Integrating biomarker discovery techniques into rationally designed nanoconstructs may lead to improvements in disease-specific diagnosis and treatment.
Keywords
Metabolomics; Silicon quantum dots; Theranostics; Cardiac ischemia; Myocardial infarction
Date
2013
Source
Theranostics, vol.3(9), pp.719 - 728
Item Type
Journal Article
Publisher
Ivyspring International Publisher
DOI
10.7150/thno.5010
Publisher's Version
http://dx.doi.org/10.7150/thno.5010
Rights Statement
This is an open-access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by-nc-nd/3.0/). Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited.

Contact Us
  • Admin

Hosted by Tuwhera, an initiative of the Auckland University of Technology Library

 

 

Browse

Open ResearchTitlesAuthorsDateSchool of Engineering, Computer and Mathematical Sciences - Te Kura Mātai Pūhanga, Rorohiko, PāngarauTitlesAuthorsDate

Alternative metrics

 

Statistics

For this itemFor all Open Research

Share

 
Follow @AUT_SC

Contact Us
  • Admin

Hosted by Tuwhera, an initiative of the Auckland University of Technology Library